Last edition
News about "pan-Canadian Pharmaceutical Alliance (pCPA) "
Novartis Signs Brain Delivery Deal With Sironax, Wraps pCPA Talks on Cosentyx Reimbursement
Novartis has signed an exclusive option agreement with Chinese biotech firm Sironax to potentially acquire its proprietary Brain Delivery Module (BDM) platform and concluded negotiations with the pan-Canadian Pharmaceutical Alliance (pCPA) on the public reimbursement of Cosentyx.
Pan-Canadian Pharmaceutical Alliance (pCPA) | 11/07/2025 | By Dineshwori | 300
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members